Assessment of vaccination coverage among adults 30-49 years of age following a mass diphtheria vaccination campaign: Ukraine, April 1995
- PMID: 10657220
- DOI: 10.1086/315568
Assessment of vaccination coverage among adults 30-49 years of age following a mass diphtheria vaccination campaign: Ukraine, April 1995
Abstract
Ukraine has been experiencing epidemic diphtheria since 1991. In efforts to control this epidemic, a mass vaccination campaign was held in April 1995. Persons not vaccinated in the previous 3 years were considered eligible for vaccination with tetanus-diphtheria toxoids (Td). Two cluster sample surveys were conducted to determine vaccination coverage achieved. In the urban and rural survey areas, respectively, 628 and 618 persons 30-49 years of age were interviewed. Fifty-nine percent of urban and 58% of rural participants were eligible for vaccination. During the vaccination campaign, 58% (95% confidence interval [95% CI], 47.1-69.2) of eligible persons received Td in the urban area, compared with 92% (95% CI, 89.2-95.3) in the rural area. Apparent barriers to vaccination included misconceptions about the safety, efficacy, and need for booster doses of Td. Future vaccination campaigns should include targeted information and education messages. Mass vaccination campaigns can be successful in vaccinating large numbers of adults; however, in urban areas, additional efforts may be required to achieve levels of coverage adequate to confer herd immunity and interrupt the diphtheria epidemic.
Similar articles
-
Evaluation of a single dose of diphtheria-tetanus toxoids among adults in Odessa, Ukraine, 1995: immunogenicity and adverse reactions.J Infect Dis. 2000 Feb;181 Suppl 1:S203-7. doi: 10.1086/315558. J Infect Dis. 2000. PMID: 10657215 Clinical Trial.
-
Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union.J Infect Dis. 2000 Feb;181 Suppl 1:S197-202. doi: 10.1086/315557. J Infect Dis. 2000. PMID: 10657214 Clinical Trial.
-
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013. Vaccine. 2005. PMID: 15882526 Clinical Trial.
-
High tetanus and diphtheria antitoxin concentrations in Finnish adults--time for new booster recommendations?Vaccine. 2009 Aug 27;27(39):5295-8. doi: 10.1016/j.vaccine.2009.06.080. Epub 2009 Jul 9. Vaccine. 2009. PMID: 19596410 Review.
-
[The immunological basis of the administration of DTP-polio vaccine].Verh K Acad Geneeskd Belg. 2000;62(4):245-67. Verh K Acad Geneeskd Belg. 2000. PMID: 11004905 Review. Dutch.
Cited by
-
Factors associated with missed vaccination during mass immunization campaigns.J Health Popul Nutr. 2009 Jun;27(3):358-67. doi: 10.3329/jhpn.v27i3.3378. J Health Popul Nutr. 2009. PMID: 19507751 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous